Tessari Eben — SEC Form 4 filings
SEC reporting owner CIK 1867899. 33 Form 4 filings on record with FilingPulse; latest filed 2026-04-08.
Transaction summary — filings shown
Covers all 33 filings on record, filed 2024-03-05 to 2026-04-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 34 legs across 24 filings — 628,733 shares, $19,653,642 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 128.
- Largest priced transaction: sale of 138,064 shares @ $33.20 ($4,583,725) in Kiniksa Pharmaceuticals International, plc, filed 2025-08-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Kiniksa Pharmaceuticals International, plc (KNSA) | CHIEF STRATEGY OFFICER | 33 | — | 34 legs · 628,733 sh · $19,653,642 | 128 |
Form 4 filings — Tessari Eben
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-08 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 2,726 · Tax withholding (F): 846 @ $48.94 · Option exercise (M): 2,726 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Grant/award (A): 365 @ $24.16 · Option exercise (M): 5,975 · Tax withholding (F): 1,756 @ $48.13 · Grant/award (A): 33,200 (derivative) @ $0 · Grant/award (A): 8,300 (derivative) @ $0 · Grant/award (A): 16,600 (derivative) @ $0 · +3 more | EDGAR |
| 2025-12-17 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 6,000 @ $8.83 · Sale (S): 12,048 @ $41.56 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2025-12-01 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 200 @ $22.89 · Sale (S): 200 @ $42.89 · Option exercise (M): 200 (derivative) @ $0 | EDGAR |
| 2025-11-19 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 6,500 @ $8.83 · Sale (S): 645 @ $40.08 · Sale (S): 11,825 @ $41.30 · Option exercise (M): 6,500 (derivative) @ $0 | EDGAR |
| 2025-10-16 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 6,500 @ $8.83 · Sale (S): 11,815 @ $37.65 · Sale (S): 553 @ $37.99 · Option exercise (M): 6,500 (derivative) @ $0 | EDGAR |
| 2025-10-01 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 42,000 @ $17.92 · Sale (S): 42,000 @ $38.33 · Option exercise (M): 42,000 (derivative) @ $0 | EDGAR |
| 2025-09-17 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 6,500 @ $8.83 · Sale (S): 16,044 @ $36.45 · Sale (S): 356 @ $37 · Option exercise (M): 6,500 (derivative) @ $0 | EDGAR |
| 2025-09-08 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 38,725 @ $15.50 · Option exercise (M): 46,546 @ $15.52 · Sale (S): 85,271 @ $35.52 · Option exercise (M): 13,389 @ $15.52 · Sale (S): 13,389 @ $35.66 · Option exercise (M): 38,725 (derivative) @ $0 · +2 more | EDGAR |
| 2025-09-03 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 1,746 · Option exercise (M): 1,773 · Option exercise (M): 2,726 · Tax withholding (F): 3,022 @ $33.49 · Option exercise (M): 1,964 · Tax withholding (F): 950 @ $34.28 · +11 more | EDGAR |
| 2025-08-20 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 6,500 @ $8.83 · Sale (S): 16,100 @ $33.77 · Sale (S): 100 @ $34.44 · Option exercise (M): 6,500 (derivative) @ $0 | EDGAR |
| 2025-08-07 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Grant/award (A): 752 @ $15.63 · Option exercise (M): 38,928 @ $10.36 · Option exercise (M): 30,444 @ $12.97 · Option exercise (M): 32,710 @ $11.10 · Option exercise (M): 25,896 @ $11.97 · Option exercise (M): 10,636 @ $10.76 · +7 more | EDGAR |
| 2025-07-16 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 6,500 @ $8.83 · Sale (S): 18,900 @ $28.72 · Option exercise (M): 6,500 (derivative) @ $0 | EDGAR |
| 2025-06-18 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 6,500 @ $8.83 · Sale (S): 17,300 @ $28.28 · Option exercise (M): 6,500 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 10,319 @ $10.36 · Sale (S): 10,319 @ $30.38 · Option exercise (M): 15,506 @ $10.36 · Sale (S): 15,506 @ $30.46 · Option exercise (M): 45,042 @ $10.36 · Sale (S): 45,042 @ $30.51 · +3 more | EDGAR |
| 2025-05-21 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 7,000 @ $3.80 · Sale (S): 12,000 @ $26.41 · Option exercise (M): 7,000 (derivative) @ $0 | EDGAR |
| 2025-05-05 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Grant/award (A): 4,975 (derivative) @ $0 · Grant/award (A): 5,224 (derivative) @ $0 · Grant/award (A): 8,042 (derivative) @ $0 · Grant/award (A): 8,302 (derivative) @ $0 | EDGAR |
| 2025-04-16 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 7,000 @ $3.80 · Sale (S): 5,579 @ $20.19 · Sale (S): 6,421 @ $20.74 · Option exercise (M): 7,000 (derivative) @ $0 | EDGAR |
| 2025-04-09 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 2,726 · Tax withholding (F): 801 @ $20.28 · Option exercise (M): 2,726 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 1,773 · Option exercise (M): 1,746 · Tax withholding (F): 521 @ $21.77 · Tax withholding (F): 513 @ $21.77 · Grant/award (A): 39,364 (derivative) @ $0 · Grant/award (A): 9,828 (derivative) @ $0 · +3 more | EDGAR |
| 2025-03-19 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 1,964 · Tax withholding (F): 577 @ $22.61 · Option exercise (M): 1,964 (derivative) @ $0 | EDGAR |
| 2025-03-12 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 7,000 @ $3.80 · Sale (S): 12,409 @ $21.06 · Option exercise (M): 7,000 (derivative) @ $0 | EDGAR |
| 2025-02-12 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 7,000 @ $3.80 · Sale (S): 14,000 @ $19.57 · Option exercise (M): 7,000 (derivative) @ $0 | EDGAR |
| 2025-01-15 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 7,000 @ $3.80 · Sale (S): 12,323 @ $18.13 · Sale (S): 1,677 @ $19.08 · Option exercise (M): 7,000 (derivative) @ $0 | EDGAR |
| 2024-12-18 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 16,017 @ $1.59 · Sale (S): 23,017 @ $20.44 · Option exercise (M): 16,017 (derivative) @ $0 | EDGAR |
| 2024-11-20 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 10,000 @ $1.59 · Sale (S): 17,000 @ $21.04 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-10-17 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 10,000 @ $1.59 · Sale (S): 17,000 @ $26.87 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-09-25 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 10,000 @ $1.59 · Sale (S): 17,500 @ $24.99 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-09-04 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 4,499 · Tax withholding (F): 1,322 @ $26.74 · Option exercise (M): 1,964 @ $0 · Tax withholding (F): 577 @ $26.74 · Grant/award (A): 6,981 (derivative) @ $0 · Grant/award (A): 36,300 (derivative) @ $0 · +3 more | EDGAR |
| 2024-08-29 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 10,000 @ $1.59 · Sale (S): 17,500 @ $26.91 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-04-08 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 2,726 · Tax withholding (F): 801 @ $17.90 · Grant/award (A): 36,300 (derivative) @ $0 · Grant/award (A): 5,585 (derivative) @ $0 · Grant/award (A): 6,981 (derivative) @ $0 · Option exercise (M): 2,726 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 1,773 · Tax withholding (F): 521 @ $19.70 · Option exercise (M): 1,773 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 656 @ $1.59 · Sale (S): 1,189 @ $22.03 · Option exercise (M): 656 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1867899 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →